Samsung Biologics earns A+ in KCGS ESG review, ranks top 1.8% in Korea – CHOSUNBIZ

Among 1087 companies evaluated by KCGS, Samsung Biologics was one of 18 to receive an A+ after lifting scores across all ESG categories Samsung …

Read More